Loading...

Nachrichtenliste

PAC-1, the first anti-cancer agent, has shown great promise in human cancer clinical trials

2023-01-09


PAC-1, the first anti-cancer agent, has shown great promise in human cancer clinical trials

Scientists from the University of Illinois at Urbana-Champaign and other institutes found that PAC-1 effectively blocked tumor growth in five patients with neuroendocrine cancer and reduced tumor size in two of them in clinical trials, while also showing some therapeutic activity against sarcomas. PAC-1, a drug that stimulates programmed cell death in cancer cells, was found in phase I clinical trials to have only mild side effects in patients with advanced cancer.

Wir möchten Cookies verwenden, um Ihre Nutzung dieser Website besser zu verstehen und Ihre Erfahrung bei zukünftigen Besuchen der Website zu verbessern. Sie können diese Einstellung in Ihren Browsereinstellungen ändern. Weitere Informationen zur Verwendung von Cookies finden Sie in unserer Datenschutzrichtlinie.